文献速递围术期管理与 ERAS急腹症与外科感染

围术期加巴喷丁对术后疼痛缓解及阿片停药的影响:随机临床试验

Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2018-01-01

IMPORTANCE: Guidelines recommend using gabapentin to decrease postoperative pain and opioid use, but significant variation exists in clinical practice.…

要点

  • 围术期加巴喷丁不缩短术后疼痛缓解时间。
  • 加巴喷丁使阿片停药率提高24%,效果 modest。
  • 不良事件及因镇静头晕停药率两组无显著差异。

核心结论

  • 围术期加巴喷丁对术后疼痛缓解无影响,但对促进阿片停药有 modest 效果。

研究设计与样本

  • 随机双盲安慰剂对照试验,单中心三级教学医院,筛选1805例18-75岁拟行指定手术患者,随机分配202例至活性安慰剂组、208例至加巴喷丁组,意向性分析,术后随访2年。

主要发现

  • 不良事件数量及因镇静或头晕停药率无显著差异(安慰剂组42/202[20.8%],加巴喷丁组52/208[25.0%])。

关键数值与推荐

  • 加巴喷丁用法:术前1200 mg,术后600 mg每日三次,共72小时;对照为术前劳拉西泮0.5 mg,术后安慰剂。
  • 主要结局疼痛缓解定义为连续5次报告手术部位平均疼痛数字评分0/10。

临床怎么用

  • 可考虑围术期使用加巴喷丁以促进术后阿片停药,但不应期望其加速疼痛缓解。
  • 需进一步研究确定特定手术中的最佳剂量和时机。

局限性

  • 单中心研究,8%随机患者失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Guidelines recommend using gabapentin to decrease postoperative pain and opioid use, but significant variation exists in clinical practice. OBJECTIVE: To determine the effect of perioperative gabapentin on remote postoperative time to pain resolution and opioid cessation. DESIGN, SETTING, AND PARTICIPANTS: A randomized, double-blind, placebo-controlled trial of perioperative gabapentin was conducted at a single-center, tertiary referral teaching hospital. A total of 1805 patients aged 18 to 75 years scheduled for surgery (thoracotomy, video-assisted thoracoscopic surgery, total hip replacement, total knee replacement, mastectomy, breast lumpectomy, hand surgery, carpal tunnel surgery, knee arthroscopy, shoulder arthroplasty, and shoulder arthroscopy) were screened. Participants were enrolled from May 25, 2010, to July 25, 2014, and followed up for 2 years postoperatively. Intention-to-treat analysis was used in evaluation of the findings. INTERVENTIONS: Gabapentin, 1200 mg, preoperatively and 600 mg, 3 times a day postoperatively or active placebo (lorazepam, 0.5 mg) preoperatively followed by inactive placebo postoperatively for 72 hours. MAIN OUTCOMES AND MEASURES: Primary outcome was time to pain resolution (5 consecutive reports of 0 of 10 possible levels of average pain at the surgical site on the numeric rating scale of pain). Secondary outcomes were time to opioid cessation (5 consecutive reports of no opioid use) and the proportion of participants with continued pain or opioid use at 6 months and 1 year. RESULTS: Of 1805 patients screened for enrollment, 1383 were excluded, including 926 who did not meet inclusion criteria and 273 who declined to participate. Overall, 8% of patients randomized were lost to follow-up. A total of 202 patients were randomized to active placebo and 208 patients were randomized to gabapentin in the intention-to-treat analysis (mean [SD] age, 56.7 [11.7] years; 256 (62.4%) women and 154 (37.6%) men). Baseline characteristics of the groups were similar. Perioperative gabapentin did not affect time to pain cessation (hazard ratio [HR], 1.04; 95% CI, 0.82-1.33; P = .73) in the intention-to-treat analysis. However, participants receiving gabapentin had a 24% increase in the rate of opioid cessation after surgery (HR, 1.24; 95% CI, 1.00-1.54; P = .05). No significant differences were noted in the number of adverse events as well as the rate of medication discontinuation due to sedation or dizziness (placebo, 42 of 202 [20.8%]; gabapentin, 52 of 208 [25.0%]). CONCLUSIONS AND RELEVANCE: Perioperative administration of gabapentin had no effect on postoperative pain resolution, but it had a modest effect on promoting opioid cessation after surgery. The routine use of perioperative gabapentin may be warranted to promote opioid cessation and prevent chronic opioid use. Optimal dosing and timing of perioperative gabapentin in the context of specific operations to decrease opioid use should be addressed in further research. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01067144.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Hah J, Mackey SC, Schmidt P, et al. Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial. JAMA Surg. 2018. PMID: 29238824. doi:10.1001/jamasurg.2017.4915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。